Terms: = Brain cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Clinical Outcome
5 results:
1. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
2. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
[TBL] [Abstract] [Full Text] [Related]
3. Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas.
Lucio-Eterovic AK; Cortez MA; Valera ET; Motta FJ; Queiroz RG; Machado HR; Carlotti CG; Neder L; Scrideli CA; Tone LG
BMC Cancer; 2008 Aug; 8():243. PubMed ID: 18713462
[TBL] [Abstract] [Full Text] [Related]
4. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma.
Pfister S; Rea S; Taipale M; Mendrzyk F; Straub B; Ittrich C; Thuerigen O; Sinn HP; Akhtar A; Lichter P
Int J Cancer; 2008 Mar; 122(6):1207-13. PubMed ID: 18058815
[TBL] [Abstract] [Full Text] [Related]
5. Gene expression profiling and subgroup identification of oligodendrogliomas.
Huang H; Okamoto Y; Yokoo H; Heppner FL; Vital A; Fevre-Montange M; Jouvet A; Yonekawa Y; Lazaridis EN; Kleihues P; Ohgaki H
Oncogene; 2004 Aug; 23(35):6012-22. PubMed ID: 15208679
[TBL] [Abstract] [Full Text] [Related]
